FORTRESS BIOTECH
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Dec 2018)
What this means for you
This application is over — abandoned 03 Dec 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86590594
- Mark type
- Stylized text
- Filed
- 08 Apr 2015
- Published for opposition
- 01 Sept 2015
- Abandoned
- 03 Dec 2018
- Attorney of record
- Devon E. White
Goods and services
- Class 005 — Pharmaceuticals: Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, infectious diseases, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, neurological disorders, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, immunologic deficiency syndromes, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer´s disease, Huntington´s disease, Parkinson, cerebral palsy, brain injury, spinal cord injury, seizure disorders, congenital disorders, metabolic disorders, viral and infectious diseases and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; Pharmaceutical products for the treatment and normalization of disorders of the body's circulatory system; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Owner
- FORTRESS BIOTECH, INC., New York, NY, US
- FORTRESS BIOTECH, INC., BURLINGTON, MA, US
- Coronado Biosciences, Inc., Burlington, MA, US
Prosecution history
- 03 Dec 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 03 Dec 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 02 May 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2018 — SOU EXTENSION 5 GRANTED
- 27 Apr 2018 — SOU EXTENSION 5 FILED
- 27 Apr 2018 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Oct 2017 — SOU EXTENSION 4 GRANTED
- 26 Oct 2017 — SOU EXTENSION 4 FILED
- 26 Oct 2017 — SOU TEAS EXTENSION RECEIVED
- 14 Apr 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Apr 2017 — SOU EXTENSION 3 GRANTED
- 11 Apr 2017 — SOU EXTENSION 3 FILED
- 11 Apr 2017 — SOU TEAS EXTENSION RECEIVED
- 06 Apr 2017 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED